论文部分内容阅读
2010年,“虽然”没有重大的高血压临床试验结果揭晓,但有许多亚组分析,如ACCORD-BP (Action to Control Cardiovascular Risk in Diabetes ), NAVIGATOR ( Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research) , INVEST-BP Goals ( International Verapamil SR/Trandolapril Study)